Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FADS1 | O60427 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 3/20 | 0.39 |
| ▸ | USP1 | O94782 | 9/20 | 0.39 |
| ▸ | WDR48 | Q8TAF3 | 9/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.39 |
| ▸ | VCP | P55072 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | IGF1R | P08069 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL786509 | 0.90 | USP1 (0.45) | FADS1USP1WDR48CYP1A2CYP2D6 | |
| SCHEMBL785653 | 0.90 | USP1 (0.46) | FADS1USP1WDR48CYP1A2CYP2D6 | |
| SCHEMBL785480 | 0.89 | USP1 (0.45) | FADS1USP1WDR48CYP1A2CYP2D6 | |
| SCHEMBL786128 | 0.89 | USP1 (0.45) | FADS1USP1WDR48CYP1A2CYP2D6 | |
| SCHEMBL786736 | 0.89 | USP1 (0.44) | USP1WDR48CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL786288 | 0.88 | USP1 (0.43) | FADS1USP1WDR48CYP1A2CYP2D6 | |
| SCHEMBL786241 | 0.88 | USP1 (0.44) | USP1WDR48CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL786372 | 0.88 | USP1 (0.44) | USP1WDR48CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL785482 | 0.87 | USP1 (0.44) | USP1WDR48CYP1A2CYP2D6CYP2C19 | |
| SCHEMBL786391 | 0.82 | CYP1A2 (0.57) | USP1WDR48CYP1A2CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8633210-B2 | Triazole compounds useful as protein kinase inhibitors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2014-01-21 | — | — | US | disclosed |
| US-20120071657-A1 | TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071657-A1 | TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS | GSK3B, GSK3A, CDK19 | FADS1 3442/4885ACHE 946/4885USP1 3070/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.